PLAINSBORO, N.J., March 17 (Bernama-GLOBE NEWSWIRE) -- Integra
LifeSciences Holdings Corporation (Nasdaq:IART), a global leader in
medical technology, announces the launch of its new CUSA® Clarity
ultrasonic tissue ablation platform designed to deliver an innovative,
integrated system for enhanced performance and long-lasting surgeon
comfort in neurosurgical cases.
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/8b5375f4-19a1-46ed-9d75-880d2ddd6006
Integra’s CUSA® Clarity was engineered to maximize surgical performance for surgeons, staff and patients through a system that provides power, precision and comfort for complex neurosurgery. The unique CUSA® Clarity system is the only ultrasonic tissue ablation system that combines a tough tissue tip, continuous tissue contact, a precision and ergonomic handpiece, and adaptive power all in one system. These four integrated components provide a greater than 50 percent increase in fibrous tissue removal rate over the CUSA® Excel system.
http://mrem.bernama.com/viewsm.php?idm=28705
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/8b5375f4-19a1-46ed-9d75-880d2ddd6006
Integra’s CUSA® Clarity was engineered to maximize surgical performance for surgeons, staff and patients through a system that provides power, precision and comfort for complex neurosurgery. The unique CUSA® Clarity system is the only ultrasonic tissue ablation system that combines a tough tissue tip, continuous tissue contact, a precision and ergonomic handpiece, and adaptive power all in one system. These four integrated components provide a greater than 50 percent increase in fibrous tissue removal rate over the CUSA® Excel system.
No comments:
Post a Comment